UMB-136


CAS No. : 2109805-83-4

2109805-83-4
Price and Availability of CAS No. : 2109805-83-4
Size Price Stock
100 mg Get quote
250 mg Get quote
500 mg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-119490
M.Wt: 417.50
Formula: C24H27N5O2
Purity: >98 %
Solubility: 10 mM in DMSO
Introduction of 2109805-83-4 :

UMB-136 is a bromodomain inhibitor. UMB-136 is a promising latency-reversing agent (LRA) for HIV-1 eradication. UMB-136 reactivates HIV-1 in multiple cell models. UMB-136 enhances HIV-1 transcription and increases viral production through the release of P-TEFb[1]. In Vitro:UMB-136 (5 μM; 24 h) significantly induces HIV-1 reactivation[1].
UMB-136 (2.5 μM; 24 h) enhances HIV-1 transcription and viral production by releasing P-TEFb[1].
UMB-136 (2.5 or 5 μM) reverses HIV-1 latency in multiple cell models (THP89GFP, J-Lat full-length (dEnv) clones, primary CD4+ T cell) of HIV-1 latency[1].
UMB-136 (2.5 μM) synergizes with other LRAs (Prostratin HY-107421 or SAHA) to reverse HIV-1 latency in J-Lat cell lines[1].
Combined treatment with UMB-136 (2.5 μM) and PKC activators reverses HIV-1 latency in patient-derived resting CD4+ T cells[1].

Your information is safe with us.